BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22144487)

  • 1. Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.
    Nichols FC; Bajrami B; Clark RB; Housley W; Yao X
    Infect Immun; 2012 Feb; 80(2):860-74. PubMed ID: 22144487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyromonas gingivalis lipids and diseased dental tissues.
    Nichols FC; Rojanasomsith K
    Oral Microbiol Immunol; 2006 Apr; 21(2):84-92. PubMed ID: 16476017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.
    Darveau RP; Pham TT; Lemley K; Reife RA; Bainbridge BW; Coats SR; Howald WN; Way SS; Hajjar AM
    Infect Immun; 2004 Sep; 72(9):5041-51. PubMed ID: 15321997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of Phosphoglycerol Dihydroceramide Produced by Periodontal Pathogen
    Yamada C; Akkaoui J; Ho A; Duarte C; Deth R; Kawai T; Nichols F; Lakshmana MK; Movila A
    Front Immunol; 2020; 11():591571. PubMed ID: 33329577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis.
    Nichols FC; Riep B; Mun J; Morton MD; Bojarski MT; Dewhirst FE; Smith MB
    J Lipid Res; 2004 Dec; 45(12):2317-30. PubMed ID: 15466368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2.
    Wang YH; Nemati R; Anstadt E; Liu Y; Son Y; Zhu Q; Yao X; Clark RB; Rowe DW; Nichols FC
    Bone; 2015 Dec; 81():654-661. PubMed ID: 26409254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system.
    Bainbridge BW; Coats SR; Darveau RP
    Ann Periodontol; 2002 Dec; 7(1):29-37. PubMed ID: 16013214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.
    Kanzaki H; Movila A; Kayal R; Napimoga MH; Egashira K; Dewhirst F; Sasaki H; Howait M; Al-Dharrab A; Mira A; Han X; Taubman MA; Nichols FC; Kawai T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):452-462. PubMed ID: 28153611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide.
    Al-Qutub MN; Braham PH; Karimi-Naser LM; Liu X; Genco CA; Darveau RP
    Infect Immun; 2006 Aug; 74(8):4474-85. PubMed ID: 16861633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 secretion from gingival fibroblasts treated with interleukin-1beta: effects of lipid extracts from Porphyromonas gingivalis or calculus.
    Nichols FC; Levinbook H; Shnaydman M; Goldschmidt J
    J Periodontal Res; 2001 Jun; 36(3):142-52. PubMed ID: 11453112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Sphingolipids and Serine Dipeptide Lipids Underestimated Virulence Factors of Porphyromonas gingivalis?
    Olsen I; Nichols FC
    Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29632248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50.
    Rangarajan M; Aduse-Opoku J; Paramonov N; Hashim A; Bostanci N; Fraser OP; Tarelli E; Curtis MA
    J Bacteriol; 2008 Apr; 190(8):2920-32. PubMed ID: 18263730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of toll-like receptor expression by Porphyromonas gingivalis.
    Wara-aswapati N; Chayasadom A; Surarit R; Pitiphat W; Boch JA; Nagasawa T; Ishikawa I; Izumi Y
    J Periodontol; 2013 Jul; 84(7):1010-8. PubMed ID: 23003918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide Preparation Derived From
    Qiu C; Yuan Z; He Z; Chen H; Liao Y; Li S; Zhou W; Song Z
    Front Cell Infect Microbiol; 2021; 11():606986. PubMed ID: 33816329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine Lipids of Porphyromonas gingivalis Are Agonists for Toll-Like Receptor 2.
    Nichols FC; Clark RB; Liu Y; Provatas AA; Dietz CJ; Zhu Q; Wang YH; Smith MB
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine/Glycine Lipid Recovery in Lipid Extracts From Healthy and Diseased Dental Samples: Relationship to Chronic Periodontitis.
    Nichols FC; Bhuse K; Clark RB; Provatas AA; Carrington E; Wang YH; Zhu Q; Davey ME; Dewhirst FE
    Front Oral Health; 2021; 2():698481. PubMed ID: 35048038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LptO (PG0027) Is Required for Lipid A 1-Phosphatase Activity in Porphyromonas gingivalis W50.
    Rangarajan M; Aduse-Opoku J; Hashim A; McPhail G; Luklinska Z; Haurat MF; Feldman MF; Curtis MA
    J Bacteriol; 2017 Jun; 199(11):. PubMed ID: 28320881
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A.
    Ogawa T; Asai Y; Makimura Y; Tamai R
    Front Biosci; 2007 May; 12():3795-812. PubMed ID: 17485340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of Porphyromonas gingivalis lipopolysaccharide alter lipidation of autophagic protein, microtubule-associated protein 1 light chain 3, LC3.
    Blasi I; Korostoff J; Dhingra A; Reyes-Reveles J; Shenker BJ; Shahabuddin N; Alexander D; Lally ET; Bragin A; Boesze-Battaglia K
    Mol Oral Microbiol; 2016 Dec; 31(6):486-500. PubMed ID: 26452236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway.
    Ogawa T; Asai Y; Hashimoto M; Takeuchi O; Kurita T; Yoshikai Y; Miyake K; Akira S
    Int Immunol; 2002 Nov; 14(11):1325-32. PubMed ID: 12407023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.